Navigation Links
Watson's Generic Yaz(R) Receives FDA Approval
Date:11/29/2011

PARSIPPANY, N.J., Nov. 29, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Vestura(TM) (3 mg drospirenone and 0.02 mg ethinyl estradiol), a generic version of Bayer's Yaz(R) oral contraceptive product.  Watson is currently involved in patent litigation with Bayer concerning this product. 

Yaz(R) had total U.S. sales of $173 million for the twelve months ending September 30, 2011, according to IMS Health. Watson's Vestura(TM) is indicated for the prevention of pregnancy and for the treatment of moderate acne in women at least 14 years old only if the patient desires an oral contraceptive for birth control.

About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement
Statements contained in this press release that refer to non-historical facts are forward-looking statements that reflect Watson's current perspective of existing information as of the date of this release. It is important to note that Watson's goals and expectations are not predictions of actual performance. Actual results may differ materially from Watson's current expectations depending upon a number of factors, risks and uncertainties
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus
2. Mylan Launches Generic Version of Percodan® Tablets
3. Mylan Launches Generic Version of Sandostatin®
4. Due to Generic Erosion, the Hypertension Drug Market Will Decline by $3 Billion from 2009 to 2019
5. Generic Drug Sector Gets Better Information on API Manufacturing Costs from Thomson Reuters and Rondaxe Enterprises
6. Thomson Reuters Explores the Opportunities and Challenges of Entering the Japanese Generic Drug Market
7. Hypertension Drug Market Will Experience Only Modest Annual Decline Through 2018, Despite Generic Erosion Of Many Branded Agents
8. Forty-two of Simceres Generic Drugs Enter Chinas Essential Drug List
9. GPhA Says BIO Cries Wolf on Senate Biogenerics Proposal
10. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets
11. Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 PMG Research, Inc. announced ... is a network of sites that provide clinical research services ... million patient lives through its partnerships with large physician practices ... hub site locations in the Southeastern United States and spans ... the board will be held by: Dr. Robert ...
(Date:11/26/2014)... The Pittcon marketing department is pleased to announce ... app, Pittcon 2015 . The ... for iOS and Android devices and the Kindle Fire, ... after the event. It acts as an all-inclusive real-time ... Conferee Networking sessions and short courses. , The Pittcon ...
(Date:11/26/2014)... 2014 Deep Research Report on ... report on the Global Palmitic Acid industry. For ... basic information, including definition, classification, application, industry chain ... etc. , For international and China market ... in China and other countries or regions ...
(Date:11/24/2014)... Nov. 24, 2014  IGI Laboratories, Inc. (NYSE MKT: ... specialty generic pharmaceutical company, today announced it has submitted ... U.S. Food and Drug Administration (FDA), which brings the ... seven, with eighteen submissions now pending at the FDA. ... CEO of the Company, commented, "Our team here at ...
Breaking Biology Technology:PMG Research Names Medical Advisory Board 2PMG Research Names Medical Advisory Board 3Pittcon Releases 2015 Mobile App 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 3IGI Laboratories, Inc. Announces ANDA Submission 2
... Dr. Brad Thompson, President,and CEO of Oncolytics Biotech ... overview of the Company at the 7th Annual ... at 2:15 p.m. PT. The conference will be ... October 29-31, 2008., A live audio link ...
... 21 ,Cephalon, Inc. (Nasdaq: CEPH ) and ... of a Paragraph IV Certification Notice Letter on ... (ANDA) submitted to the U.S.,Food and Drug Administration ... and sell a generic version of the 15 ...
... Care Clients in Kentucky, Indiana,Tennessee, Georgia, Alabama, Ohio ... Nikon Instruments Inc.,announced that it has appointed ... Kentucky, Indiana, Tennessee, Georgia,Alabama, Ohio and West Virginia. ... products in the United States, will sell,Nikon,s market ...
Cached Biology Technology:Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2008 2Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules 2Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules 3Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules 4Nikon Instruments Appoints LABSCO its Clinical Distributor in Six States 2
(Date:11/11/2014)... , Nov. 11, 2014  Forensicon, Inc., a ... is pleased to announce the promotion of Yaniv ... of Digital Forensics. In Schiff,s new role as Director, ... team of digital forensics examiners and provide leadership within ... Photo - http://photos.prnewswire.com/prnh/20141110/157719 Schiff ...
(Date:11/6/2014)... A groundbreaking paper from a team of Florida State ... how plants could adapt to and survive environmental swings ... in the latest issue of the journal The ... complex of DNA and proteins) is organized in a ... some genes are turned on and others are turned ...
(Date:11/5/2014)... Redmond has dedicated his career to understanding the ... general audience. , As deputy director and regional ... Nevada,s Desert Research Institute, Redmond has more than ... and dissemination of climate data to the general ... in San Francisco on December 15-19, 2014 the ...
Breaking Biology News(10 mins):Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Maize analysis yields whole new world of genetic science 2Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2
... care, new research suggests that early infection may create ... the immune system. Researchers at the University of Colorado ... one-time infection as newborns didn't learn as well as ... their immunity was challenged. The research is in February's ...
... University Medical Center implanted Artificial Silicon Retina (ASR) microchips ... loss caused by retinitis pigmentosa (RP). The implant is ... an inch thick, less than the thickness of a ... 25. The fifth patient is scheduled for a later ...
... Johns Hopkins researchers have discovered that the antibiotic minocycline ... and central nervous system, problems that can develop even ... body. , Five monkeys infected with simian immunodeficiency virus ... with minocycline had less damage to brain cells, less ...
Cached Biology News:Rats infected as newborns grew up vulnerable to memory problems during an immune challenge 2Rats infected as newborns grew up vulnerable to memory problems during an immune challenge 3Ophthalmologists implant five patients with artificial silicon retina microchip 2Ophthalmologists implant five patients with artificial silicon retina microchip 3Antibiotic might fight HIV-induced neurological problems 2Antibiotic might fight HIV-induced neurological problems 3
This kit is designed to select cells labeled with biotinylated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
... The Hamamatsu C9136 FLIM system combines the ... image with the resolution of the optical microscope ... Using a short, pulsed light source for excitation, ... captured and the lifetime of the decay measured. ...
... ScriptCap™ m7G Capping system ... and all of the components ... 0 on the end of ... These kits feature high efficiency ...
Extracti-Gel D Detergent Removing Gel...
Biology Products: